Literature DB >> 24113801

Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.

Hugo Dias Hoffmann-Santos1, Claudete Rodrigues Paula, Ana Caroline Akeme Yamamoto, Tomoko Tadano, Rosane C Hahn.   

Abstract

We conducted this cross-sectional retrospective study using clinical and laboratory data from two tertiary hospitals in Cuiabá, Mato Grosso, Brazil, in order to explore the risk factors and estimate mortality, prevalence and lethality of candidemia between 2006 and 2011. A total of 130 episodes of candidemia were identified. The prevalence of candidemia was 1.8 per 1,000 admissions, the mortality rate was 0.9 per 1,000 admissions, and the lethality was 49.2 %. The main agent in this population was Candida parapsilosis (n = 50), followed by C. albicans (n = 45). Comparison between the numbers of episodes in the two triennia revealed that the non-albicans group grew by 48.2 %. The distribution of yeast species of Candida per hospital unit revealed that C. albicans was more prevalent than C. parapsilosis in the adult ICU and C. parapsilosis was more prevalent than C. albicans in the neonatal ICU. Patients remained hospitalized for an average of 53.5 days. Central venous catheters, parenteral nutrition and age were the variables that proved to be independent in the multivariate analysis and that maintained a statistically significant association with the incidence of death in patients with candidemia. The annual prevalence of candidemia showed a significant increase in the second triennium (2009-2011) compared with the first (2006-2008) probably due to increased exposure to risk factors: central venous catheter, H2 blockers, nutrition parenteral corticosteroids and mean hospital duration.

Entities:  

Mesh:

Year:  2013        PMID: 24113801     DOI: 10.1007/s11046-013-9705-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  34 in total

1.  Epidemiological and clinical characteristics of nosocomial candidiasis in university hospitals in Cuiabá--Mato Grosso, Brazil.

Authors:  Ana Caroline Akeme Yamamoto; Claudete Rodrigues de Paula; Luciana Basili Dias; Tomoko Tadano; Évelin Rodrigues Martins; Janaína Vasconcelos Ribeiro de Souza Amadio; Rosane Christine Hahn
Journal:  Rev Iberoam Micol       Date:  2012-01-25       Impact factor: 1.044

2.  Neonatal candidiasis: epidemiology, risk factors, and clinical judgment.

Authors:  Daniel K Benjamin; Barbara J Stoll; Marie G Gantz; Michele C Walsh; Pablo J Sánchez; Abhik Das; Seetha Shankaran; Rosemary D Higgins; Kathy J Auten; Nancy A Miller; Thomas J Walsh; Abbot R Laptook; Waldemar A Carlo; Kathleen A Kennedy; Neil N Finer; Shahnaz Duara; Kurt Schibler; Rachel L Chapman; Krisa P Van Meurs; Ivan D Frantz; Dale L Phelps; Brenda B Poindexter; Edward F Bell; T Michael O'Shea; Kristi L Watterberg; Ronald N Goldberg
Journal:  Pediatrics       Date:  2010-09-27       Impact factor: 7.124

Review 3.  Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.

Authors:  Markus Ruhnke; Volker Rickerts; Oliver A Cornely; Dieter Buchheidt; Andreas Glöckner; Werner Heinz; Rainer Höhl; Regine Horré; Meinolf Karthaus; Peter Kujath; Birgit Willinger; Elisabeth Presterl; Peter Rath; Jörg Ritter; Axel Glasmacher; Cornelia Lass-Flörl; Andreas H Groll
Journal:  Mycoses       Date:  2011-07       Impact factor: 4.377

4.  Epidemiology of adult candidemia at Chiang Mai University Hospital.

Authors:  Romanee Chaiwarith; Pooriwat Ounbang; Chantana Khamwan; Nontakan Nuntachit; Thira Sirisanthana; Khuanchai Supparatpinyo
Journal:  Southeast Asian J Trop Med Public Health       Date:  2011-11       Impact factor: 0.267

5.  Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain.

Authors:  R Cisterna; G Ezpeleta; O Telleria; J Guinea; B Regueiro; J Garcia-Rodríguez; J Esperalba
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

6.  [Candidemia in a tertiary hospital in northeastern Brazil].

Authors:  Sylvia Lemos Hinrichsen; Erika Falcão; Tatiana Aguiar Santos Vilella; Arnaldo Lopes Colombo; Márcio Nucci; Líbia Moura; Leandro Rêgo; Conceição Lira; Luciano Almeida
Journal:  Rev Soc Bras Med Trop       Date:  2008 Jul-Aug       Impact factor: 1.581

7.  Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005).

Authors:  Joaquín Gómez; Elisa García-Vázquez; Cristina Espinosa; Joaquín Ruiz; Manuel Canteras; Alicia Hernández-Torres; Victor Baños; José Antonio Herrero; Mariano Valdés
Journal:  Rev Iberoam Micol       Date:  2009-07-18       Impact factor: 1.044

8.  [Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility].

Authors:  João Cesar Beenke França; Clea Elisa Lopes Ribeiro; Flávio de Queiroz-Telles
Journal:  Rev Soc Bras Med Trop       Date:  2008 Jan-Feb       Impact factor: 1.581

9.  Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.

Authors:  Arnaldo L Colombo; Thaís Guimarães; Ligia R B F Silva; Leila Paula de Almeida Monfardini; Anna Karenine B Cunha; Patrícia Rady; Thelma Alves; Robert C Rosas
Journal:  Infect Control Hosp Epidemiol       Date:  2007-04-13       Impact factor: 3.254

10.  Fungemia in cancer patients in Brazil: predominance of non-albicans species.

Authors:  M Nucci; M I Silveira; N Spector; F Silveira; E Velasco; C A Martins; A Derossi; A L Colombo; W Pulcheri
Journal:  Mycopathologia       Date:  1998       Impact factor: 2.574

View more
  7 in total

1.  Candida species biotypes and polyclonality of potentially virulent Candida albicans isolated from oral cavity of patients with orofacial clefts.

Authors:  Marcelo Fabiano Gomes Boriollo; Mateus Cardoso Oliveira; Vanessa Bassinello; Paula Cristina Aníbal; Thaísla Andrielle da Silva; Jeferson Júnior da Silva; Rodrigo Carlos Bassi; Manoel Francisco Rodrigues Netto; Carlos Tadeu Dos Santos Dias; José Francisco Höfling
Journal:  Clin Oral Investig       Date:  2021-11-18       Impact factor: 3.573

2.  Risk factors for Candida parapsilosis bloodstream infection in a neonatal intensive care unit: a case-control study.

Authors:  Carmine Garzillo; Maria Bagattini; Lidija Bogdanović; Anna Di Popolo; Vita Dora Iula; Maria Rosaria Catania; Francesco Raimondi; Maria Triassi; Raffaele Zarrilli
Journal:  Ital J Pediatr       Date:  2017-01-19       Impact factor: 2.638

3.  Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis.

Authors:  Shakti Singh; Sunna Nabeela; Ashley Barbarino; Ashraf S Ibrahim; Priya Uppuluri
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 4.  Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers.

Authors:  Daniel Archimedes da Matta; Ana Carolina Remondi Souza; Arnaldo Lopes Colombo
Journal:  J Fungi (Basel)       Date:  2017-05-17

5.  Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data.

Authors:  Giuseppina Caggiano; Grazia Lovero; Osvalda De Giglio; Giovanna Barbuti; Osvaldo Montagna; Nicola Laforgia; Maria Teresa Montagna
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

6.  Emerging Invasive Fungal Infections: Clinical Features and Controversies in Diagnosis and Treatment Processes.

Authors:  Hongliang Zhang; Aiqun Zhu
Journal:  Infect Drug Resist       Date:  2020-02-20       Impact factor: 4.003

7.  Secular trends of candidemia at a Brazilian tertiary care teaching hospital.

Authors:  Paula Rocha Braga; Isabela L Cruz; Isadora Ortiz; Gloria Barreiros; Simone A Nouér; Marcio Nucci
Journal:  Braz J Infect Dis       Date:  2018-08-16       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.